Patents by Inventor Steven Bruce Cohen

Steven Bruce Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY DRUG CONJUGATES
    Publication number: 20160137730
    Abstract: This application discloses anti-P-cadherin antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
    Type: Application
    Filed: November 13, 2015
    Publication date: May 19, 2016
    Applicant: Novartis AG
    Inventors: Tinya ABRAMS, Steven Bruce Cohen, Jason Damiano, Clemens Dürr, Thomas Huber, Daniel Menezes, Kathy Miller, Katherine Rendahl, Jean-Michel Rene Rondeau
  • ANTIBODY DRUG CONJUGATES
    Publication number: 20150320880
    Abstract: The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
    Type: Application
    Filed: May 20, 2015
    Publication date: November 12, 2015
    Applicant: NOVARTIS AG
    Inventors: Tinya ABRAMS, Steven Bruce COHEN, Christie P. Fanton, Catrin FINNER, Thomas HUBER, Kathy Miller, Siew Ho SCHLEYER, Kathrin Ulrike Tissot-Daguette
  • ANTIBODY DRUG CONJUGATES
    Publication number: 20140271688
    Abstract: The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicants: IRM LLC, NOVARTIS AG
    Inventors: Tinya Abrams, Steven Bruce Cohen, Christie P. Fanton, Thomas Huber, Kathy Miller, Siew Ho Schleyer, Kathrin Ulrike Tissot-Daguette, Catrin Finner
  • PCSK9 ANTAGONISTS
    Publication number: 20130315927
    Abstract: The present invention provides antibody antagonists against proprotein convertase subtilisin/kexin type 9a (“PCSK9”) and methods of using such antibodies.
    Type: Application
    Filed: February 10, 2012
    Publication date: November 28, 2013
    Applicants: Novartis AG, IRM LLC
    Inventors: Joshua Goldstein, Steven Bruce Cohen, Andrew Schumacher, David Langdon Yowe